maps glp 1 program GLP-1 Receptor Agonist Market Size, Share & Forecast, 2026–2034 Mind - MAPS GLP-1 is

Syra Hanif M.D

Pain decreased Tissue improved Fat thickness reduced (confirmed by ultrasound) Even women who *didnt lose weight* saw real results This might be the first published evidence of a GLP-1 medication showing promise in treating lipedema - not just weight, but symptoms, pain, and fat tissue behavior

Hjerpsted JB, Flint A, Brooks A, Axelsen MB, Kvist T, Blundell J

Compared to the control animals, those administered L-carnitine exhibited increases in L-carnitine metabolites such as L-carnitine (ratio: 4.4), butyrylcarnitine (ratio: 7.7), and O-acetylcarnitine (ratio: 14), and a decrease in the L-carnitine (LC)/acyl-L-carnitine (ALC) ratio (Fig